Altered expression of the catenin p120 in human cancer: implications for tumor progression
- 1 December 2002
- journal article
- review article
- Published by Elsevier BV in Differentiation
- Vol. 70 (9-10), 583-589
- https://doi.org/10.1046/j.1432-0436.2002.700911.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A novel role for p120 catenin in E-cadherin functionThe Journal of cell biology, 2002
- High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Regulation of Rho GTPases by p120-cateninCurrent Opinion in Cell Biology, 2001
- Co-downregulation of cell adhesion proteins α- and β-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomasHuman Pathology, 2001
- The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progressionBreast Cancer Research, 2001
- Inhibition of RhoA by p120 cateninNature, 2000
- Up-regulated cytoplasmic expression, with reduced membranous distribution, of thesrc substrate p120ctn in gastric carcinomaThe Journal of Pathology, 1999
- p120ctn Acts as an Inhibitory Regulator of Cadherin Function in Colon Carcinoma CellsThe Journal of cell biology, 1999
- The Catenin p120ctn Interacts with Kaiso, a Novel BTB/POZ Domain Zinc Finger Transcription FactorMolecular and Cellular Biology, 1999
- Loss of p120ctn in human colorectal cancer predicts metastasis and poor survivalCancer Letters, 1998